These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 8934373
1. Safety of the calcium antagonist lacidipine evaluated from a phase III-IV trial database. Lindholm LH, Tcherdakoff P, Zanchetti A. J Hypertens Suppl; 1996 Sep; 14(2):S15-20. PubMed ID: 8934373 [Abstract] [Full Text] [Related]
3. Lacidipine: a review of its use in the management of hypertension. McCormack PL, Wagstaff AJ. Drugs; 2003 Sep; 63(21):2327-56. PubMed ID: 14524737 [Abstract] [Full Text] [Related]
4. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial. Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palù C, Hansson L, Magnani B, Rahn KH, Reid JL, Rodicio J, Safar M, Eckes L, Rizzini P, European Lacidipine Study on Atherosclerosis investigators. Circulation; 2002 Nov 05; 106(19):2422-7. PubMed ID: 12417537 [Abstract] [Full Text] [Related]
6. Clinical position of lacidipine, a new dihydropyridine calcium antagonist, in the treatment of hypertension. Leonetti G. J Cardiovasc Pharmacol; 1991 Nov 05; 18 Suppl 11():S18-21. PubMed ID: 1725445 [Abstract] [Full Text] [Related]
10. Evaluating the benefits of an antihypertensive agent using trials based on event and organ damage: the Systolic Hypertension in the Elderly Long-term Lacidipine (SHELL) trial and the European Lacidipine Study on Atherosclerosis (ELSA). Zanchetti A. J Hypertens Suppl; 1995 Dec 05; 13(4):S35-9. PubMed ID: 8824685 [Abstract] [Full Text] [Related]
11. Pharmacological interventions for hypertension in children. Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh R. Evid Based Child Health; 2014 Sep 05; 9(3):498-580. PubMed ID: 25236305 [Abstract] [Full Text] [Related]
16. A double-blind comparison of the efficacy and safety of lacidipine and hydrochlorothiazide in essential hypertension. The Southern Italy Lacidipine Study Group. Chiariello M. J Cardiovasc Pharmacol; 1991 Sep 05; 17 Suppl 4():S35-7. PubMed ID: 1726004 [Abstract] [Full Text] [Related]
18. Comparative study of lacidipine and nifedipine SR in the treatment of hypertension: an Italian multicenter study. The Northern Italian Study Group of Lacidipine in Hypertension. Leonetti G. J Cardiovasc Pharmacol; 1991 Sep 05; 17 Suppl 4():S31-4. PubMed ID: 1726003 [Abstract] [Full Text] [Related]
19. Long-term antihypertensive treatment with lacidipine, a new long-acting calcium antagonist. Nami R, Rizzini P, Buracchi P, Pavese G, Gennari C. J Cardiovasc Pharmacol; 1991 Sep 05; 18 Suppl 11():S22-5. PubMed ID: 1725446 [Abstract] [Full Text] [Related]
20. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palù C, Hansson L, Magnani B, Rahn KH, Reid J, Rodicio J, Safar M, Eckes L, Ravinetto R. J Hypertens; 1998 Jul 05; 16(7):949-61. PubMed ID: 9794735 [Abstract] [Full Text] [Related] Page: [Next] [New Search]